Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,581.00
(
1.15%
)
US TECH 100
23,529.60
(
0.04%
)
Dow Jones
46,208.47
(
1.38%
)
Brent Oil
98.48
(
1.75%
)
Bitcoin
71,148.00
(
0.35%
)
News Focus
News Focus
Post# of 257273
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 241585

Wednesday, 04/27/2022 4:24:10 PM

Wednesday, April 27, 2022 4:24:10 PM

Post# of 257273
PFE/BHVN—Migraine drug, rimegepant approved by EU with the brand name, Vydura (a/k/a Nurtec ODT in US):

https://finance.yahoo.com/news/pfizer-biohaven-vydura-rimegepant-granted-104500600.html

PFE has the ex-US commercial rights to Vydura from a deal with BHVN struck in Nov 2021 (#msg-166695371). The sales could be large enough to move the needle even for a company as large as PFE.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today